US FDA announces launch of Safe Use Initiative

By  

Reactions Weekly, Vol. 1, Iss. 1278, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

By Lesko Lawrence J   Zineh Issam  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 507-512

Future Medicine

Access to resources Recommend Favorite

FDA launches initiative for safe use of inhalation drugs in kids

By  

Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The US FDA and Health Canada have both announced that they are reviewing the cardiovascular (CV) safety of dronedarone [Multaq]

By  

Reactions Weekly, Vol. 1, Iss. 1362, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite